The putative G-protein coupled estrogen receptor agonist G-1 suppresses proliferation of ovarian and breast cancer cells in a GPER-independent manner

American Journal of Translational Research

Volumn 4, Issue 4, 2012, Pages 390-402

  Wang, Cheng ^a   Lv, Xiangmin ^a,c   Jiang, Chao ^a   Davis, John S ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

^c HUNAN NORMAL UNIVERSITY   (China)

Author keywords

Breast cancer; Estrogen receptors; G 1; G15; GPR30 GPER; Ovarian cancer

Indexed keywords

1 [4 (6 BROMOBENZO[1,3]DIOXOL 5YL) 3A,4,5,9B TETRAHYDRO 3H CYCLOPENTA [C]QUINOLIN 8 YL] ETHANONE; ANTINEOPLASTIC AGENT; G 1; G PROTEIN COUPLED RECEPTOR 30; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CELL STRAIN HEK293; CONTROLLED STUDY; FEMALE; GRANULOSA CELL TUMOR; HUMAN; HUMAN CELL; OVARY CANCER; TUMOR CELL LINE;

EID: 84868010705     PISSN: None     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Strom A, Treuter E, Warner M, Gustafsson JA. Estrogen receptors: how do they signal and what are their targets. Physiological Review 2007; 87: 905-931.
2. Ho S-M. Estrogen, Progesterone and Epithelial Ovarian Cancer. Reproductive Biology and Endocrinology 2003; 1: 73.
3. Thomas P, Pang Y, Filardo EJ, Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005; 146: 624-632.
4. Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Molecular Endocrinology 2000; 14: 1649-1660.
5. Revankar CM, Cimino CF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005; 307: 1625-1630.
6. Kang L, Zhang X, Xie Y, Tu Y, Wang D, Liu Z, Wang ZY. Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. Molecular Endocrinology 2010; 24: 709-721.
7. Levin ER. G Protein-Coupled Receptor 30: Estrogen Receptor or Collaborator? Endocrinology 2009; 150: 1563-1565.
8. Pedram A, Razandi M, and Levin ER. Nature of functional estrogen receptors at the plasma membrane. Molecular Endocrinology 2006; 20: 1996-2009.
9. Prossnitz ER, Barton M. The G-protein-coupled estrogen receptor GPER in health and disease. Nature Review Endocrinology 2011; 7: 715-726.
10. Bologa CG, Revankar CM, Young SM, Edwards BS, Arterburn JB, Kiselyov AS, Parker MA, Tkachenko SE, Savchuck NP, Sklar LA, Oprea TI, Prossnitz ER. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nature Chemical Biology 2006; 2: 207-212.
11. Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK, Bologa CG, Leitao A, Brailoiu E, Deliu E, Dun NJ, Sklar LA, Hathaway HJ, Arterburn JB, Oprea TI, Prossnitz ER. In vivo effects of a GPR30 antagonist. Nature Chemical Biology 2009; 5: 421-427.
12. Blasko E, Haskell CA, Leung S, Gualtieri G, Halks-Miller M, Mahmoudi M, Dennis MK, Prossnitz ER, Karpus WJ, Horuk R. Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis. Journal of Neuroimmunology 2009; 214: 67-77.
13. Balhuizen A, Kumar R, Amisten S, Lundquist I, Salehi A. Activation of G protein-coupled receptor 30 modulates hormone secretion and counteracts cytokine-induced apoptosis in pancreatic islets of female mice. Molecular & Cellular Endocrinology 2010; 320: 16-24.
14. Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, Oprea TI, Prossnitz ER, Musti AM, Andò S, Maggiolini M. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Research 2007; 67: 1859-1866.
15. Chan QK, Lam HM, Ng CF, Lee AY, Chan ES, Ng HK, Ho SM, Lau KM. Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest. Cell Death and Differentiation 2010; 17: 1511-1523.
16. Jamieson S, Fuller PJ. Molecular Pathogenesis of Granulosa Cell Tumors of the Ovary. Endocrine Reviews 2012; 33: 109-144.
17. - mice. Proc Natl Acad Sci USA 2010; 107: 6453-6458.
18. Imai M, Muraki M, Takamatsu K, Saito H, Seiki M, Takahashi Y. Spontaneous transformation of human granulosa cell tumours into an aggressive phenotype: a metastasis model cell line. BMC Cancer 2008; 8: 319.
19. Wang C, Prossnitz ER, Roy SK. Expression of G protein-coupled receptor 30 in the hamster ovary: differential regulation by gonadotropins and steroid hormones. Endocrinology 2007; 148: 4853-4864.
20. Wang C, Prossnitz ER, Roy SK. G protein- coupled receptor 30 expression Is required for estrogen stimulation of primordial follicle formation in the hamster ovary. Endocrinology 2008:149: 4452-4461.
21. Sharma G, Prossnitz ER. Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic beta-cells. Endocrinology 2011; 152: 3030-3039.
22. Lindsey SH, Carver KA, Prossnitz ER, Chappell MC. Vasodilation in response to the GPR30 agonist G-1 is not different from estradiol in the mRen2.Lewis female rat. Journal of Cardiovascular Pharmacology 2011; 57: 598-603.
23. Peyton C, Thomas P. Involvement of epidermal growth factor receptor signaling in estrogen inhibition of oocyte maturation mediated through the G protein-coupled estrogen receptor (GPER) in zebrafish (Daniorerio). Biology of Reproduction 2011; 85: 42-50.
24. Tica AA, Dun EC, Tica OS, Gao X, Arterburn JB, Brailoiu GC, Oprea TI, Brailoiu E. G protein-coupled estrogen receptor 1-mediated effects in the rat myometrium, American Journal of Physiology: Cell Physiology 2011; 301: 01262-1269.
25. Cheng SB, Graeber CT, Quinn JA, Filardo EJ. Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 (GPR30/GPER) from the plasma membrane towards the nucleus. Steroids 2011; 76: 892-896.
26. Filardo E, Quinn J, Pang Y, Graeber C, Shaw S, Dong J. Thomas P. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology 2007; 148: 3236-3245.
27. Filardo EJ, Quinn JA, Frackelton AR Jr, Bland KI. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Molecular Endocrinology 2002; 16: 70-84.
28. Carmeci C, Thompson DA, Ring HZ, Francke U, Weigel RJ. Identification of a Gene (GPR30) with Homology to the G-Protein-Coupled Receptor Superfamily Associated with Estrogen Receptor Expression in Breast Cancer. Genomics 1997; 45: 607-617.
29. Maggiolini M, Vivacqua A, Fasanella G, Recchia AG, Sisci D, Pezzi V, Montanaro D, Musti AM, Picard D, Andò S. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. Journal of Biological Chemistry 2004; 279: 27008-27016.
30. Smith HO, Arias-Pulido H, Kuo DY, Howard T, Qualls CR, Lee SJ, Verschraegen CF, Hathaway HJ, Joste NE, Prossnitz ER. GPR30 predicts poor survival for ovarian cancer. Gynecological Oncology 2009; 114: 465-471.
31. Schumer ST, Cannistra SA. Granulosa cell tu- mor of the ovary, Journal of Clinical Oncology 2003; 21: 1180-1189.
32. Staibano S, Franco R, Mezza E, Chieffi P, Sinisi A, Pasquali D, Errico ME, Nappi C, Tremolaterra F, Somma P, Mansueto G, De Rosa G. Loss of oestrogen receptor beta, high PCNA and p53 expression and aneuploidy as markers of worse prognosis in ovarian granulosa cell tumours. Histopathology 2003; 43: 254-262.
33. East N, Alobaid A, Goffin F, Ouallouche K, Gauthier P. Granulosa cell tumour: a recurrence 40 years after initial diagnosis. Journal of Obstetrics and Gynaecology (Canada) 2005; 27: 363-364.
34. Wei Y, Zhang Z, Liao H, Wu L, Wu X, Zhou D, Xi X, Zhu Y, Fen Y. Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation. Oncology Report 2012; 27: 504-510.
35. Robker RL, Richards JS. Hormonal control of the cell cycle in ovarian cells: proliferation versus differentiation. Biology of Reproduction 1998; 59: 476-482.